PEPSICO INC
For the period ended Sep 6, 2025. Filed Oct 9, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 6, 2025 · Filed Oct 9, 2025
PEP$143.61+1.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statement of Comprehensive Income –
| 12 Weeks Ended | 36 Weeks Ended | |||
|---|---|---|---|---|
| 9/6/2025 | 9/7/2024 | 9/6/2025 | 9/7/2024 | |
| Net income | $2,618 | $2,945 | $5,740 | $8,092 |
| Other comprehensive income/(loss), net of taxes: | ||||
| Net currency translation adjustment | 39 | (512) | 1,436 | (961) |
| Net change on cash flow hedges | 23 | (24) | 27 | 21 |
| Net pension and retiree medical adjustments | 21 | 21 | 12 | 41 |
| Net change on available-for-sale debt securities and other | 410 | (351) | 540 | (219) |
| Total other comprehensive income/(loss), net of taxes | 493 | (866) | 2,015 | (1,118) |
| Comprehensive income | 3,111 | 2,079 | 7,755 | 6,974 |
| Less: Comprehensive income attributable tononcontrolling interests | 15 | 15 | 40 | 37 |
| Comprehensive Income Attributable to PepsiCo | $3,096 | $2,064 | $7,715 | $6,937 |
Condensed Consolidated Statement of Cash Flows
| 36 Weeks Ended | ||
|---|---|---|
| 9/6/2025 | 9/7/2024 | |
| Operating Activities | ||
| Net income | $5,740 | $8,092 |
| Depreciation and amortization | 2,315 | 2,118 |
| Impairment and other charges | 1,960 | 10 |
| Product recall-related impact | — | 184 |
| Cash payments for product recall-related impact | (5) | (138) |
| Operating lease right-of-use asset amortization | 489 | 438 |
| Share-based compensation expense | 207 | 260 |
| Restructuring and impairment charges | 567 | 415 |
| Cash payments for restructuring charges | (554) | (284) |
| Acquisition and divestiture-related charges | 308 | 7 |
| Cash payments for acquisition and divestiture-related charges | (80) | (4) |
| Pension and retiree medical plan expenses | 164 | 114 |
| Pension and retiree medical plan contributions | (400) | (300) |
| Deferred income taxes and other tax charges and credits | 30 | 124 |
| Tax payments related to the Tax Cuts and Jobs Act (TCJ Act) | (772) | (579) |
| Change in assets and liabilities: | ||
| Accounts and notes receivable | (1,747) | (1,521) |
| Inventories | (449) | (492) |
| Prepaid expenses and other current assets | (223) | (200) |
| Accounts payable and other current liabilities | (1,647) | (2,312) |
| Income taxes payable | 6 | 426 |
| Other, net | (441) | (138) |
| Net Cash Provided by Operating Activities | 5,468 | 6,220 |
| Investing Activities | ||
| Capital spending | (2,499) | (2,850) |
| Sales of property, plant and equipment | 272 | 177 |
| Acquisitions, net of cash acquired, investments in noncontrolled affiliates and purchases of intangible and other assets | (3,176) | (31) |
| Divestitures, sales of investments in noncontrolled affiliates and other assets | 5 | 145 |
| Short-term investments, by original maturity: | ||
| More than three months - purchases | (190) | (425) |
| More than three months - maturities | 425 | — |
| Three months or less, net | 43 | 4 |
| Other investing, net | (117) | 15 |
| Net Cash Used for Investing Activities | (5,237) | (2,965) |
(Continued on following page)
Condensed Consolidated Statement of Cash Flows (continued)
| 36 Weeks Ended | ||
|---|---|---|
| 9/6/2025 | 9/7/2024 | |
| Financing Activities | ||
| Proceeds from issuances of long-term debt | $8,179 | $4,014 |
| Payments of long-term debt | (3,245) | (2,883) |
| Short-term borrowings, by original maturity: | ||
| More than three months - proceeds | 5,528 | 3,808 |
| More than three months - payments | (5,417) | (4,177) |
| Three months or less, net | 445 | 101 |
| Cash dividends paid | (5,692) | (5,369) |
| Share repurchases | (752) | (760) |
| Proceeds from exercises of stock options | 76 | 138 |
| Withholding tax payments on restricted stock units (RSUs) and performance stock units (PSUs) converted | (112) | (132) |
| Other financing | (18) | (22) |
| Net Cash Used for Financing Activities | (1,008) | (5,282) |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | 395 | (391) |
| Net Decrease in Cash and Cash Equivalents and Restricted Cash | (382) | (2,418) |
| Cash and Cash Equivalents and Restricted Cash, Beginning of Year | 8,553 | 9,761 |
| Cash and Cash Equivalents and Restricted Cash, End of Period | $8,171 | $7,343 |
| Supplemental Non-Cash Activity | ||
| Right-of-use assets obtained in exchange for lease obligations | $542 | $869 |
| Investment obtained for certain assets (see Notes 4 and 9) | $554 | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.